Astellas Pharma (4503) · InitiativeAchieved
Acquisition of cancer immunocellular technology through the acquisition of Xyphos
First written in FY2020-Q3. 1 of 1 entries say "Achieved", first in FY2020-Q3. Latest entry: FY2020-Q3.
1entries
1years
0from disclosures
How it moved
Same theme, other companies
Acquisition of the ACCEL cell therapy platform through the acquisition of XyphosA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first